Core-biopsy needle

Core Needle Biopsy of Right Breast Mass... 

Heilo, A., Stenwig, A.E. Liver hemangioma US-guided 18-gauge core-needle biopsy. Radiology 1997 204 719—722... 

Heilo A. Tumors in the mediastinum Ultrasound-guided histologic core-needle biopsy. Radiology. 1993 189 143-146. 

Casella R, Bubendorf L, Sauter G, et al. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. / Urol. 1998 160 406. 

Bubendorf L, Tapia C, Gasser TC, et al. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. Hum Pathol. 1998 29 949. 

Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy A report of 38 cases and review of the literature. Arch Pathol Lab Med. 2008 132 979-983. 

Jacobs TW, Chen YY, Guinee Jr DG, et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy Are there predictors of outcome on surgical excision Am J Clin Pathol. 2005 124 342-354. 

Jacobs TW, Siziopikou KP, Prioleau JE, et al. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor Mod Pathol. 1998 11 259-264. 

Routinely processed cytologic specimens fixed in formalin (e.g., fine-needle aspiration [FNA]) smears, touch imprints of core needle biopsies, effusions) can also be used to assess the receptor status and HER2 protein by immunohistochemistry. ... 

Cheung YC, Wan YL, Lui KW, Lee KF (2000) Sonographically guided core-needle biopsy in the diagnosis of superficial lymphadenopathy. J Clin Ultrasound 28 283-289 Christensen R (2001) Invasive radiology forpediatrictrauma. Sem Ped Surg 10 7-11... 

Core-needle biopsy samples are fixed in formalin and embedded in paraffin wax 3- to 4 pm-thick sections are cut and then stained with hematoxylin/eosin. Further immunohistochemical analysis of the material is then possible for specific indications requested. In all cases, the presence of a cytopathologist, to assess specimen adequacy during the procedure, would result in a high diagnostic outcome (Baled and Guy 2001) however, if this is not possible, two needle punctures during the first session should be performed. 

Garcfa-Vilanova-Comas A, Fuster-Diana C, Cubells-Parrilla M, Perez-Ferriols MD, P6rez-Valles A, Roig-Vila JV. Nicolau syndrome after lidocaine injection and cold application a rare complication of breast core needle biopsy. Int J Dermatol 2011 50(1) 78-80. 

Solomon et al. (2002) used the PAKY robotic system in 16 patients during CT-guided procedures. The accuracy in the phantom calibration test was 0.6° angular and 1.65 mm linear. All 23 procedures (RF ablation, core needle biopsy, nephrostomy, and neobladder access) were performed successfully without complication. However, in four cases, the target was not met adequately, and fine-tuning adj ustment with joystick control was required to ultimately reach the target. In all cases, however, the study showed that the use of the robot reduced radiation exposure for the patient and medical personnel. 

Fig.4.4a-d. Different types of core needles are available (a) to perform manual (b), semi-automatic (c) or automatic (d) core-needle biopsy... 

Fig. 4.5. a Semi-automatic core-needle biopsy method for palpable breast lesions, b The biopsy-needle is advanced until contact is made with the lesion, c The inner needle is then pushed forward and captures tissue in the sampling chamber, d Then the outer cutter is advanced and cuts the entrapped core specimen from the surrounding tissue... 

Fig. 4.6. Diagnostic management of nonpalpable breast lesions. FNAB, fine-needle aspiration biopsy CNB, core-needle biopsy...

Ballo MS, Sneige N (1996) Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. A comparative study of 124 women. Cancer 78 773-777... 

Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, Fowble B (2001) Local recurrence of breast cancer in the stereotactic core needle biopsy site case reports and review of the literature. Breast J 7 124-127... 

Meyer JE, Smith DN, Lester Sc, Kaelin C, DiPiro PJ, Denison CM, Christian RL, Harvey SC,Selland DL, Durfee SM (1999) Large-core needle biopsy of nonpalpable breast lesions. JAMA 281 1683-1641... 

Nath ME, Robinson TM, Tobon H, Chough DM, Sumkin JH (1995) Automated large-core needle biopsy of surgically removed breast lesions comparison of samples obtained with 14-, 16 and 18-gauge needles. Radiology 197 739-742... 

Perez-Fuentes JA, Longobardi IR, Acosta VF, Marin CE, Liberman L (2001) Sonographically-guided directional vacuum-assisted breast biopsy preliminary experience in Venezuela. AJR Am J Roentgenol 177 1459-1463 Philpotts LE, Lee CH, Horvath LJ, Tocino I (1997) Canceled stereotactic core-needle biopsy of the breast analysis of 89 cases. Radiology 205 423-428... 

Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH (1999) Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol 172 683-687... 

Pagani JJ (1983) Biopsy of focal hepatic lesions. Comparison of 18 and 22 gauge needles. Radiology 147 673-675 Piccinino F etal. (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2 165-173 Poe RH etal. (1984) Predicting risk of pneumothorax in needle biopsy of the lung. Chest 85 232-235 Pramesh CS et al. (2001) Core needle biopsy for bone tumours. Eur J Surg Oncol 27 668-671... 

Breasts Susceptibility factors for benign proliferative epithelial disorders of the breast have been the subject of a cohort study of 68 132 postmenopausal women who were prospectively followed those who had an open surgical biopsy or a core needle biopsy had histological sections obtained for centralized pathology review. Over an average of 7.8 years of follow-up, 1792 women with benign proliferative disorders were identified. Women who had used postmenopausal hormones for 15 years or more had a twofold increase in the risk of such disorders of the breast compared with women who had never used postmenopausal hormones (HR = 2.03 95% Cl = 1.73, 2.38) and the increase in risk was observed both for proliferation without atypia and for atypical hyperplasia. Furthermore, the risk of such complications decreased with time since cessation of use so that there was essentially no increase in risk five or more years after withdrawal of HRT [25. ... 

---